OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to supercharge weight loss
Disease control CompletedThis study tested whether two experimental drugs, AZD9550 and AZD6234, given together as weekly shots, help people with obesity or overweight lose more weight than a placebo or either drug alone. 377 adults aged 18-75 with a BMI of 27 or higher and at least one weight-related hea…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New daily pill shows promise for weight loss in obesity trial
Disease control CompletedThis Phase 2 study tested a once-daily pill called RGT001-075 in 267 adults who are obese or overweight with weight-related health problems like high blood pressure or sleep apnea. The goal was to see if the drug helps with weight loss and is safe. Participants took either the dr…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: Regor Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New combo shot helps east asians shed pounds in major trial
Disease control CompletedThis study tested a new medicine called CagriSema (a mix of two drugs) in 331 East Asian adults with obesity or overweight. Participants received a weekly injection for about 1.5 years. The main goal was to see how much weight they lost compared to another drug. The study is comp…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo shot shows promise for weight loss in chinese adults
Disease control CompletedThis study tested a new weekly injection called CagriSema, which combines two drugs (cagrilintide and semaglutide), to help Chinese adults with obesity or overweight lose weight. About 300 participants received either CagriSema, semaglutide alone, or a placebo for around one year…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New oral weight loss pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested a new daily pill called AZD5004 for weight loss in 310 adults with obesity or overweight who also had a weight-related health problem like high blood pressure. Participants took either the drug or a placebo for 36 weeks. The main goal was to see if the drug help…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New weekly shot helps shed pounds in obesity trial
Disease control CompletedThis study tested a new medicine called AZD6234, given as a weekly shot, to help people with obesity or overweight lose weight. About 262 adults took part for 36 weeks. The goal was to see if the drug leads to greater weight loss compared to a placebo, especially for those with w…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New Weight-Loss drug AZD5004 tested in chinese adults
Symptom relief CompletedThis early-stage study tested a new drug called AZD5004 in 45 Chinese adults who were overweight or had obesity, with or without type 2 diabetes. The main goal was to check if the drug is safe and how the body processes it, compared to a placebo. Participants took the drug or a d…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE1 • Sponsor: Eccogene • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC